President & Chief Executive Officer
Charles (Chas) McKhann was named President & Chief Executive Officer and a member of the Board of Directors in March 2021. Mr. McKhann has served in Chief Executive Officer or Chief Commercial Officer roles in four medical device companies including Torax Medical (acquired by J&J) and Intersect ENT (ticker: XENT). Previously, Mr. McKhann served in leadership roles at Boston Scientific Corporation and at Cordis, a Johnson & Johnson company. Earlier in his career, Mr. McKhann was a strategy consultant at McKinsey & Company. Mr. McKhann holds a Bachelor’s degree and Masters of Business Administration from Stanford University.